15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $822M | -$92M | 68.8% | -9.9% | -$1M | $157M | $82M |
| 2024 | $799M | -$126M | 68.3% | -10.6% | -$9M | $157M | $83M |
| 2023 | $747M | -$151M | 65.1% | -18.6% | -$108M | $94M | $33M |
| 2022 | $461M | -$20M | 73.2% | -2.9% | -$35M | — | $51M |
| 2021 | $464M | -$38M | 75.3% | -1.8% | — | — | $88M |
| 2020 | $407M | $3M | 74.9% | -1.5% | — | — | $96M |
| 2019 | $460M | -$28M | 78.1% | -4.1% | — | — | $70M |
| 2018 | $453M | $14M | 78.7% | 6.6% | — | — | $70M |
| 2017 | $434M | $6M | 78.6% | 9.4% | — | — | $81M |
| 2016 | $410M | $3M | 78.6% | 5.1% | — | — | $40M |
| 2015 | — | -$3M | — | — | — | — | $64M |
| 2014 | — | -$9M | — | — | — | $0 | $37M |
| 2013 | — | -$29M | — | — | — | — | $29M |
| 2012 | — | $43M | — | — | — | — | $31M |
| 2011 | — | -$18M | — | — | — | — | $33M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $197M | -$21M | 70.9% | -7.3% | -$28M | $221M | $120M |
| Dec '25 | $220M | -$2M | 71.1% | 0.2% | $17M | $157M | $82M |
| Sep '25 | $206M | -$23M | 72.2% | -8.3% | $2M | $157M | $63M |
| Jun '25 | $203M | -$14M | 68.7% | -7.9% | $5M | $157M | $66M |
| Mar '25 | $194M | -$53M | 62.8% | -25.2% | -$25M | $157M | $58M |
| Dec '24 | $216M | -$29M | 69.0% | -5.3% | $15M | $157M | $83M |
| Sep '24 | $197M | -$27M | 68.7% | -9.6% | $6M | $118M | $30M |
| Jun '24 | $199M | -$33M | 67.8% | -12.5% | -$732000 | $118M | $26M |
| Mar '24 | $189M | -$36M | 67.5% | -15.6% | -$29M | $118M | $27M |
| Dec '23 | $200M | -$22M | 68.2% | -9.1% | — | $94M | $33M |
| Sep '23 | $184M | -$29M | 65.1% | -13.3% | — | $70M | $34M |
| Jun '23 | $187M | -$39M | 63.9% | -19.6% | — | $51M | $38M |
| Mar '23 | $175M | -$61M | 63.0% | -34.1% | — | $45M | $50M |
| Dec '22 | $122M | -$7M | 73.0% | -9.0% | — | — | $51M |
| Sep '22 | $114M | -$11M | 73.2% | -5.1% | — | — | $52M |
| Jun '22 | $118M | $2M | 73.2% | 5.6% | — | — | $60M |
| Mar '22 | $106M | -$4M | 73.4% | -2.9% | — | — | $72M |
| Dec '21 | $125M | -$33M | 73.4% | -7.5% | — | — | $88M |
| Sep '21 | $112M | -$2M | 74.8% | -0.3% | — | — | $83M |
| Jun '21 | $121M | $2M | 77.4% | 3.5% | — | — | $80M |
How the market has priced OFIX against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Orthofix Medical Inc.'s revenue has grown 15.1% per year. These are computed facts, not advice.
As of FY2025, Orthofix Medical Inc. reported $157M of total debt against $82M of cash.
In FY2025, gross margin was 68.8%, operating margin -9.9%, and net margin -11.2%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.